Today: 20 May 2026
Klarna (KLAR) Stock Dips Below IPO Price – Will Analysts’ Bullish Forecast Come True?
20 October 2025
7 mins read

Klarna Stock Slips Below IPO Price as Fintech Giant Eyes Rebound in BNPL Boom

  • Wall Street Debut: Klarna went public on the NYSE in September 2025 under ticker “KLAR”, pricing its IPO at $40 per share and raising ~$1.37 billiontechfundingnews.com. The offering valued the Swedish buy now, pay later (BNPL) pioneer at about $15 billion, far below its 2021 private peak of $45.6 billion but well above its 2022 down-round valuation of $6.7 billiontechfundingnews.com. Shares surged ~30% on debut, opening near $52reuters.com.
  • Stock Performance: After an initial pop, Klarna’s stock has fallen below its IPO price amid broader fintech volatility. As of mid-October 2025, KLAR trades in the mid-$30s (closing at ~$35 on Oct. 17) – about 25% below its first-day close and intraday highs around $57. The company’s market capitalization is roughly $25–28 billion at current prices. Shares hit a low around $35.60 in early October during a market sell-off, though analysts note key support levels in the mid-$30s range.
  • IPO Impact and Plans: Klarna’s NYSE listing (Sept. 10, 2025) marked one of the year’s biggest fintech IPOs, signaling a thaw in the IPO market. Oversubscription drove the final offer price above the initial $35–$37 rangetechfundingnews.com. Management and early investors largely held their shares; CEO Sebastian Siemiatkowski (who owns ~7%) did not sell stock in the IPO, calling the debut “a little bit like a wedding… then life goes on”reuters.com. The listing, led by Goldman Sachs, JPMorgan, and Morgan Stanley, is seen as a bellwether for high-growth fintechs, alongside anticipated offerings from peers like Chime and Circlets2.tech.
  • Current Business Health:Klarna’s financials are improving after aggressive cost cuts. In Q2 2025, revenue grew ~20% year-on-year to $823 million, as gross merchandise volume and U.S. sales surged (U.S. revenue +38% YoY). The firm recorded its fifth consecutive quarterly operating profit ( ~$29 million adjusted operating income). However, on a net basis Klarna had a $53 million loss in Q2 due largely to one-time charges (office closures, lease exits, and stock comp costs tied to the IPO). Credit performance is steady – loan default rates improved to under 1% of BNPL volumes – and Klarna boasts a BBB credit rating with $10.4 billion in cash reserves, reinforcing its balance sheet ahead of expansion.
  • Valuation Context: Klarna’s public valuation reflects a comeback from its 2022 slump. Once Europe’s most valuable startup (at $45.6B in 2021), Klarna saw its valuation plunge ~85% to $6.7B amid the 2022 fintech rout. The 2025 IPO valuation (~$15B) essentially doubled that trough

Stock Market Today

  • Sensex and Nifty Close Higher Despite Rupee's Record Low Amid Iran Conflict
    May 20, 2026, 6:58 AM EDT. Indian stock markets ended marginally higher on Wednesday, with the BSE Sensex up 117.54 points (0.16%) at 75,318.39 and the NSE Nifty50 gaining 41 points (0.17%) to 23,659. The rupee hit a record low of 96.96 against the US dollar, weakening over 6% since the Iran conflict began. Elevated crude oil prices near USD 109 per barrel and geopolitical tensions pressured markets. Reliance Industries led gains with a 2.8% increase, supporting a broader recovery. Analysts note ongoing concerns over imported inflation, fuel costs, and external finances amid volatile global sentiment and rising bond yields. Auto, financial, and oil & gas sectors saw selective buying, reflecting cautious investor optimism.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Digi Power X (DGXX) Stock Soars on AI Data Center Breakthrough and Crypto Gains
Previous Story

Digi Power X (DGXX) Stock Soars on AI Data Center Breakthrough and Crypto Gains

GSI’s AI Breakthrough Slashes Energy by 98% – GPU-Killer Chip Sparks 200% Stock Rally
Next Story

GSI’s AI Breakthrough Slashes Energy by 98% – GPU-Killer Chip Sparks 200% Stock Rally

Go toTop